[go: up one dir, main page]

DE69822209D1 - ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON - Google Patents

ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON

Info

Publication number
DE69822209D1
DE69822209D1 DE69822209T DE69822209T DE69822209D1 DE 69822209 D1 DE69822209 D1 DE 69822209D1 DE 69822209 T DE69822209 T DE 69822209T DE 69822209 T DE69822209 T DE 69822209T DE 69822209 D1 DE69822209 D1 DE 69822209D1
Authority
DE
Germany
Prior art keywords
estron
pharmaceutical compositions
sulfamate compounds
sulfatase inhibiting
sulfatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822209T
Other languages
English (en)
Other versions
DE69822209T2 (de
Inventor
Masato Tanabe
H Peters
Wan-Ru Chao
Kazuhiko Shigeno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Original Assignee
SRI International Inc
Stanford Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SRI International Inc, Stanford Research Institute filed Critical SRI International Inc
Application granted granted Critical
Publication of DE69822209D1 publication Critical patent/DE69822209D1/de
Publication of DE69822209T2 publication Critical patent/DE69822209T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69822209T 1997-12-24 1998-12-21 "Östron-Sulfatase hemmende Östron-Sulfamatverbindungen, pharmazeutische Zusammensetzungen und Verwendungen davon" Expired - Lifetime DE69822209T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US997416 1992-12-28
US08/997,416 US6046186A (en) 1997-12-24 1997-12-24 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
PCT/US1998/027333 WO1999033858A2 (en) 1997-12-24 1998-12-21 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use

Publications (2)

Publication Number Publication Date
DE69822209D1 true DE69822209D1 (de) 2004-04-08
DE69822209T2 DE69822209T2 (de) 2005-02-17

Family

ID=25543995

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69837114T Expired - Lifetime DE69837114T2 (de) 1997-12-24 1998-12-21 Östron-Sulfatase hemmende Östron-Sulfamatverbindungen und dazugehörige pharmazeutische Zusammensetzung und Verwendungen davon
DE69822209T Expired - Lifetime DE69822209T2 (de) 1997-12-24 1998-12-21 "Östron-Sulfatase hemmende Östron-Sulfamatverbindungen, pharmazeutische Zusammensetzungen und Verwendungen davon"

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69837114T Expired - Lifetime DE69837114T2 (de) 1997-12-24 1998-12-21 Östron-Sulfatase hemmende Östron-Sulfamatverbindungen und dazugehörige pharmazeutische Zusammensetzung und Verwendungen davon

Country Status (8)

Country Link
US (1) US6046186A (de)
EP (2) EP1405860B1 (de)
JP (1) JP2001527089A (de)
KR (1) KR20010033622A (de)
AU (1) AU751732B2 (de)
CA (1) CA2318349C (de)
DE (2) DE69837114T2 (de)
WO (1) WO1999033858A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US20040214807A1 (en) * 1993-08-06 2004-10-28 D'amato Robert J. Estrogenic compounds as anti-mitotic agents
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6346510B1 (en) * 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
ATE401896T1 (de) * 1998-06-10 2008-08-15 Sterix Ltd Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US7087592B1 (en) * 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
AU2001248849A1 (en) * 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
WO2002015910A1 (en) 2000-08-18 2002-02-28 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
US20050192258A1 (en) * 2000-08-18 2005-09-01 Agoston Gregory E. Antiangiogenic agents
US7135581B2 (en) * 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
EP1343803A2 (de) * 2000-11-27 2003-09-17 EntreMed, Inc. 2-substituierte estrogene mit antiangiogenischer aktivität
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
WO2003063787A2 (en) * 2002-01-30 2003-08-07 Entremed, Inc. Non-steroidal analogs of 2-methoxyestradiol
WO2004035089A1 (ja) * 2002-10-09 2004-04-29 Kyowa Hakko Kogyo Co., Ltd. ホルモン依存性癌の治療剤
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) * 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
WO2004085459A1 (en) * 2003-03-24 2004-10-07 Sterix Limited Oestrogen derivatives as inhibitors of steroid sulphatase
US7371741B2 (en) * 2003-05-28 2008-05-13 Entremed, Inc. Estradiol derivatives and pharmaceutical compositions using same
US20070004689A1 (en) * 2004-03-12 2007-01-04 Agoston Gregory E Antiangiogenic agents
WO2005089256A2 (en) 2004-03-12 2005-09-29 Entremed, Inc. Antiangiogenic agents
GB0421106D0 (en) * 2004-09-22 2004-10-27 Sterix Ltd Compound
AU2005309455A1 (en) * 2004-11-29 2006-06-01 Entremed, Inc. A method of administering anti-angiogenic agents and a method of treating disease using same
US20060264413A1 (en) * 2005-04-18 2006-11-23 Sri International Method and composition for inhibiting cell proliferation and angiogenesis
WO2007059111A2 (en) * 2005-11-14 2007-05-24 Entremed, Inc. Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
US20070176403A1 (en) * 2006-02-01 2007-08-02 Dennis Calderone Air adjustable seat
EP2001482B1 (de) 2006-03-20 2016-08-24 CASI Pharmaceuticals, Inc. Krankheitsmodifizierende antiarthritische wirkung von 2-methoxyestradiol
US20080234243A1 (en) * 2007-01-31 2008-09-25 Lavallee Theresa M Method of treating amyloidosis mediated diseases
CN104710497B (zh) * 2013-12-14 2018-03-23 天津金耀集团有限公司 一种孕甾‑16‑烯‑3，20‑二酮甾体衍生物的合成方法
CN104710495B (zh) * 2013-12-14 2018-06-05 天津金耀集团有限公司 一种孕甾-16-烯-3，20-二酮甾体衍生物的制备方法
CN104710496B (zh) * 2013-12-14 2017-11-07 天津金耀集团有限公司 关于一种孕甾‑16‑烯‑3，20‑二酮甾体衍生物的制备方法
RU2679625C1 (ru) 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ
RU2678845C1 (ru) 2018-11-08 2019-02-04 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-7β-МЕТИЛ-D-ГОМО-6-ОКСАЭСТРА-1,3,5(10),8(9)-ТЕТРАЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ НЕГАТИВНУЮ ФОРМУ
CN109896967B (zh) * 2019-04-04 2021-10-22 上海工程技术大学 一种间二乙氨基苯酚的制备方法
CN109896966B (zh) * 2019-04-04 2021-10-22 上海工程技术大学 一种n,n-二丁基间氨基苯酚的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
ES2201101T3 (es) * 1994-04-05 2004-03-16 Celltech Therapeutics Limited Uso de inhibidores de sulfatasas de esteroides.
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors

Also Published As

Publication number Publication date
US6046186A (en) 2000-04-04
EP1405860A1 (de) 2004-04-07
WO1999033858A9 (en) 1999-10-28
DE69822209T2 (de) 2005-02-17
AU751732B2 (en) 2002-08-29
KR20010033622A (ko) 2001-04-25
WO1999033858A2 (en) 1999-07-08
WO1999033858A3 (en) 1999-09-16
CA2318349A1 (en) 1999-07-08
EP1042354B1 (de) 2004-03-03
EP1405860B1 (de) 2007-02-14
CA2318349C (en) 2008-04-22
DE69837114D1 (de) 2007-03-29
JP2001527089A (ja) 2001-12-25
AU1941699A (en) 1999-07-19
DE69837114T2 (de) 2007-12-13
EP1042354A2 (de) 2000-10-11

Similar Documents

Publication Publication Date Title
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
FI991485A0 (fi) Uusi farmaseuttinen koostumus
HUP0203973A3 (en) Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
DE69836424D1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69809928D1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
HUP0104549A3 (en) Imidazo-pyridine sulfonamide derivatives and pharmaceutical compositions thereof
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
EE200000330A (et) Farmatseutilised kompositsioonid
EP1124557A4 (de) Pharmazeutische zusammensetzung
HUP0103006A3 (en) Substituted betha-diketones, pharmaceutical compositions containing them and their use
DE69900336D1 (de) Pentoxifyllin und antizytokin enthaltende pharmazeutische zusammensetzungen
NO994436L (no) Farmasöytiske sammensetninger

Legal Events

Date Code Title Description
8364 No opposition during term of opposition